RecruitingNCT07440225
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
PHASE2 · PHASE3 · 960 planned enrolment
- Countries listed
- 12
- Registry update
- October 2, 2026
immortal.lifePublic trial registrations naming EyeBiotech Ltd. as an industry lead sponsor.
This is an independent registry-name view, not a verified corporate profile, portfolio valuation, ownership map, endorsement, or investment recommendation.
This does not mean that no transaction exists. A record appears only after its disclosure source and the connection to this exact registry sponsor identity are separately verified.
PHASE2 · PHASE3 · 960 planned enrolment
PHASE1 · PHASE2 · 33 planned enrolment